Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Social problems of porphyria]

S Tarczyńska-Nosal1, E Kostrzewska

  • 1Poradni i Pracowni Badań nad Porfiria Instytutu Hematologii i Transfuzjologii w Warszawie.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|June 26, 1998
PubMed
Summary

Late porphyria attacks can lead to long-term issues like neuropathy and disability. Patients in remission frequently require disability pensions and face challenges changing professions, with a risk of drug dependence from medications like Pethidine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Anti - T. gondii antibody concentration in sera of pregnant women in the sample of Lódź population].

Wiadomosci parazytologiczne·2006
Same author

[Uniform programme in caring for patients with acute hepatic porphyria].

Polskie Archiwum Medycyny Wewnetrznej·2002
Same author

New missense mutation in the human ferrochelatase gene in a family with erythropoietic protoporphyria: functional studies and correlation of genotype and phenotype.

Clinical chemistry·2001
Same author

[[35 Years of effort to improve the diagnosis of porphyria].

Przeglad lekarski·2000
Same author

[The course of acute hepatic porphyria].

Wiadomosci lekarskie (Warsaw, Poland : 1960)·1999
Same author

Acute hepatic porphyrias. Detection, prophylaxis and treatment.

Materia medica Polona. Polish journal of medicine and pharmacy·1996

Area of Science:

  • Medical Science
  • Neurology
  • Pharmacology

Background:

  • Acute porphyrias are rare metabolic disorders with potential long-term health consequences.
  • Understanding the late effects of porphyria is crucial for patient management and support.

Purpose of the Study:

  • To investigate the late consequences of acute porphyria attacks.
  • To assess the prevalence of disability and employment challenges in porphyria patients.
  • To evaluate medication use and the risk of drug dependence in patients with porphyria.

Main Methods:

  • Retrospective study of 312 patients with a history of acute porphyria attacks.
  • Assessment of neurological and psychological sequelae.
  • Analysis of disability pension status and employment changes in a subgroup of 200 patients in remission.

Related Experiment Videos

  • Review of medication use, specifically Dolargan (Pethidine).

    • Main Results:

    • Neuropathy was observed in 9 patients (2.9%) and psychoneurological changes in 1 patient (0.3%).
    • Among 200 patients in remission, 72 (36%) received a disability pension.
    • Patients experienced difficulties changing professions due to health reasons.
    • Dolargan (Pethidine) was frequently prescribed to patients in remission, indicating a high risk for developing drug dependence.

    Conclusions:

    • Acute porphyria can lead to significant long-term motor disability and psychoneurological issues.
    • A substantial percentage of porphyria patients require disability pensions and face vocational challenges.
    • The frequent use of Pethidine in remission poses a considerable risk of drug dependence in porphyria patients.